Global Biotech Breakthroughs

Initiator Pharma

Market Cap: SEK 224.5m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Valneva

Market Cap: €558.5m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Dynavax Technologies

Market Cap: US$1.3b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Innovent Biologics

Market Cap: HK$167.5b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Aroa Biosurgery

Market Cap: AU$217.4m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Mirum Pharmaceuticals

Market Cap: US$2.5b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Pharming Group

Market Cap: €581.3m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Captor Therapeutics Spolka Akcyjna

Market Cap: zł248.8m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

Natera

Market Cap: US$18.5b

A diagnostics company, provides molecular testing services worldwide.

Formycon

Market Cap: €522.6m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.